HIV, ANTIRETROVIRAL TREATMENT, AND STROKE IN MALAWIAN ADULTS. Issue 10 (9th September 2014)

• Record Type: Journal Article
• Authors: Benjamin, Laura; Corbett, Elizabeth; Connor, Myles; Mzinganjira, Henry; Emsley, Hedley; Bryer, Alan; Faragher, Brian; Heyderman, Robert; Allain, Theresa; Solomon, Tom
• Is Part Of: Journal of neurology, neurosurgery and psychiatry. Volume 85:Issue 10(2014)
• Page Start: e4
• Page End: e4
• Publication Date: 2014-09-09
• Subjects: EPILEPSY; Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Psychiatry -- Periodicals; 616.8
• DOI: 10.1136/jnnp-2014-309236.209
• Languages: English
• ISSNs: 0022-3050

Abstract

Abstract : Objective: We investigated HIV, its treatment and other risk factors for stroke in Malawi. Methods: We performed a prospective case-control study of 222 adults with acute stroke, confirmed by MRI in 86%, and 503 population controls, frequency-matched for age, sex and place of residence. Multivariate logistic regression models were used for case–control comparisons. Findings: HIV infection (Population Attributable Fraction [PAF] 15%) and hypertension (PAF 46%) were strongly linked to stroke. HIV was the predominant risk factor for young stroke (≤45 years), with a prevalence of 67% and an adjusted odds ratio [aOR, 95% CI] of 5.57 [2.43, 12.8]; PAF 42%. There was an increased risk of a stroke in patients with untreated HIV infection (aOR 4.48 [2.44, 8.24]), but the highest risk was in the first 6 months after starting antiretrovirals (aOR 15.6 [4.21, 46.6]). Stroke risk increased with declining CD4+ T-lymphocyte counts (p=0.008). Interpretation: HIV infection increases the risk of stroke especially ischaemic stroke in young people; this is largely driven by immunosuppression. However, there is a markedly increased stroke risk in the first 6 months of starting antiretrovirals. A better understanding of this risk is urgently needed in order to try and reduce it.